The Pharmagellan Guide to Biotech Forecasting and Valuation (Paperback)

The Pharmagellan Guide to Biotech Forecasting and Valuation By Frank S. David, Seth Robey, Andrew Matthews Cover Image
Available to SHIP now; STORE PICKUP in 7-10 days
This book cannot be returned. PRINT-ON-DEMAND; printing may add 2-4 business days.


If you're a biotech executive, investor, deal maker, entrepreneur, or adviser--or aspire to be one--then you need to know how to build and analyze forecasts and valuation models of R&D-stage drugs.

THE PHARMAGELLAN GUIDE TO BIOTECH FORECASTING AND VALUATION is a comprehensive, thoroughly referenced handbook to creating and interpreting financial models for early-stage biopharma assets and companies.

- Vetted benchmarks for key drivers of income, expenses, and valuation.
- Proprietary analyses by Pharmagellan's experienced consulting team.
- More than 150 current references from peer-reviewed research, industry white papers, and SEC filings.

Whether you're making investment decisions, pitching to potential partners or funders, or assessing your own R&D program, this is the one-stop guide you need by your side.

Product Details
ISBN: 9780998407500
ISBN-10: 099840750X
Publisher: Pharmagellan, LLC
Publication Date: January 6th, 2017
Pages: 138
Language: English